31 C
Lucknow
July 16, 2024
The Hona News
health

Receipt of novel hormonal therapy for advanced prostate cancer varies with race



For Medicare beneficiaries with advanced prostate cancer (PCa), receipt of novel hormonal therapy (NHT) agents varies with race, according to a study published online Dec. 1 in JAMA Network Open.



Source link

Related posts

All we know about Google Pixel Watch 3

asdavi92

Model uses AI to create better outcomes and save costs for prediabetic patients

asdavi92

Mandhana equals Mithali’s all-time record

asdavi92

Leave a Comment